Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020
GHDx Entry last modified on: Mar 14, 2022
Blood tests
Dataset Records for Blood tests
Displaying 151 - 200 of 1806
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors
GHDx Entry last modified on: Mar 14, 2022
COVID-19 at a metropolitan region: public polices and social vulnerability within an iniquity context. Preprint
COVID-19 em uma Região Metropolitana: vulnerabilidade social e políticas públicas em contextos de desigualdades
Denmark Blood Donors are Now Being Re-examined for Coronavirus Infection
Survey:
Epi surveillance
Estonia COVID-19 Coronavirus prevalence study 2020-2023
Koroonaviiruse levimuse uuring "Covid-19 aktiivne seire"
Survey:
Epi surveillance
Sero-prevalence of anti-SARS-CoV-2 Antibodies in Addis Ababa, Ethiopia. Preprint
GHDx Entry last modified on: Mar 14, 2022
Strategies for Infection Control and Prevalence of Anti-SARS-CoV-2 IgG Antibodies in 4,554 Employees of a University Hospital in Munich, Germany. Preprint
GHDx Entry last modified on: Mar 14, 2022
A COVID-19 Hotspot Area: Activities and Epidemiological Findings
GHDx Entry last modified on: Mar 14, 2022
Canada COVID-19 Seroprevalence Report - April 2020 to January 2021
COVID-19 Public Seroprevalence Report April 2020 to January 2021
Epi surveillance:
Nationally representative
England - Coronavirus (COVID-19) Infection Survey: Antibody Data, January 2021
Coronavirus (COVID-19) Infection Survey: antibody data for the UK, January 2021
Survey:
Epi surveillance
Seroprevalence of COVID-19 virus infection in Guilan province, Iran. Preprint
GHDx Entry last modified on: Mar 14, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Among Adults in a Tropical City of the Caribbean Area, Colombia: Are We Much Closer to Herd Immunity Than Developed Countries?
GHDx Entry last modified on: Mar 14, 2022
Belgium Prevalence of anti-SARS-CoV-2 antibodies (IgG) among blood donors 2020-2021
Belgium COVID-19 Studies, Seroprevalence in Blood Donors
Infection fatality rate of SARS-CoV-2 infection in a German community with a super-spreading event. Preprint
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 transmission among children and staff in daycare centres during a nationwide lockdown in France: a cross-sectional, multicentre, seroprevalence study
GHDx Entry last modified on: Mar 14, 2022
India COVID-19 Official Government of India updates - Twitter 2020-2022
GHDx Entry last modified on: Aug 28, 2023
France COVID-19 Epidemic Monitoring Dashboard 2020-2022
Tableau de bord COVID-19 Suivi de l’épidémie de COVID-19 en France
Detection of Antibodies After Review of Covid-19 in Blood Donors (Sub-report 2)
Påvisning av antikroppar efter genomgången covid-19 hos blodgivare (Delrapport 2)
Survey:
Epi surveillance
Repeated leftover serosurvey of SARS-CoV-2 IgG antibodies, Greece, March and April 2020
GHDx Entry last modified on: Mar 14, 2022
Canada COVID-19 Seroprevalence Report - January 12, 2021
COVID-19 Seroprevalence Report January 12, 2021 - Report #4: November 2020 Survey
Canada COVID-19 Seroprevalence Report - December 18, 2020
COVID-19 Seroprevalence Report December 18, 2020 - Report #3: October 2020 Survey
Germany - Saarland antibody study on coronavirus infection completed: Institute for Virology at Saarland University Hospital presents results
GHDx Entry last modified on: Feb 10, 2022
SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states, Germany, March to June 2020
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 Seroprevalence Survey Estimates Are Affected by Anti-Nucleocapsid Antibody Decline
GHDx Entry last modified on: May 12, 2022
United States - COVID-19 Diagnostic Laboratory Testing (PCR Testing) Time Series 2020-2022
Epi surveillance:
Health facility - Subnationally representative
France Covid-19 Information - Average number of new daily hospitalizations 2020-2022
Informations Covid-19 - Nombre moyen de nouvelles hospitalisations quotidiennes
Cape Verde STEPS Noncommunicable Disease Risk Factors Survey 2020
Segundo Inquérito Nacional sobre os Fatores de Risco das Doenças Não Transmissíveis (IDNT II)
Survey:
Cross-sectional - Individual - Interview - Nationally representative
Switzerland COVID-19 PCR Antigen Tests by Region 2020
Daily record timelines by geoRegion and test type (pcr/antigen) for testsonen
Epi surveillance:
Subnationally representative
Findings from serological surveys (in August 2020) to assess the exposure of adult population to SARS Cov-2 infection in three cities of Odisha, India. Preprint.
GHDx Entry last modified on: Mar 14, 2022
Temporal trends of SARS-CoV-2 seroprevalence in transfusion blood donors during the first wave of the COVID-19 epidemic in Kenya
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 has been circulating in northeastern Brazil since February 2020: evidence for antibody detection in asymptomatic patients
GHDx Entry last modified on: Mar 14, 2022
Surveillance and Seroprevalence: Evaluation of IgG antibodies for SARS-Cov2 by ELISA in the popular neighborhood Villa Azul, Quilmes, province of Buenos Aires, Argentina. Preprint
GHDx Entry last modified on: Mar 14, 2022
Prevalence evolution of SARS-CoV-2 infection in the Municipality of São Paulo, 2020 - 2021
GHDx Entry last modified on: May 12, 2022
High anti-SARS-CoV-2 antibody seroconversion rates before the second wave in Manaus, Brazil, and the protective effect of social behavior measures: Results from the DETECTCoV-19 cohort. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2, symptom profiles and seroneutralization during the first COVID-19 wave in a suburban area, France. Preprint
GHDx Entry last modified on: Mar 14, 2022
[Prevalence of ABO and Rh Blood groups in the city of Quito-Ecuador]
Prevalencia de los grupos sanguíneos ABO y Rh en la ciudad de Quito- Ecuador
Assessing seropositivity for IgG antibodies against SARS-CoV-2 in Ahmedabad city of India: a cross-sectional study
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of SARS-CoV-2 immunoglobulin antibodies in Wuhan, China: part of the city-wide massive testing campaign
GHDx Entry last modified on: Jan 31, 2024
Prevalence and Risk Factors of Infection in the Representative COVID-19 Cohort Munich. Preprint
GHDx Entry last modified on: Mar 14, 2022
Charting Elimination in the Pandemic: A SARS-CoV-2 Serosurvey of Blood Donors in New Zealand. Preprint
GHDx Entry last modified on: Mar 14, 2022
Type 2 diabetes prevalence, awareness, and risk factors in rural Mali: a cross-sectional study
GHDx Entry last modified on: Dec 12, 2023
India Integrated Disease Surveillance Programme (IDSP): Weekly Outbreak Reports for 2024
Disease Alerts/Outbreaks Reported and Responded to by States/UTs through Integrated Disease Surveillance Programme (IDSP)
Epi surveillance:
Subnationally representative
Population-Based Serosurvey for Severe Acute Respiratory Syndrome Coronavirus 2 Transmission, Chennai, India
GHDx Entry last modified on: Jan 31, 2024
Serology- and PCR-based cumulative incidence of SARS-CoV-2 infection in adults in a successfully contained early hotspot (CoMoLo study), Germany, May to June 2020
GHDx Entry last modified on: Jan 31, 2024
India - Chennai CHILDS Trust Medical Research Foundation (CTMRF) Hospital Inpatient Data 2020
Administrative data:
Inpatient
Seropositive Prevalence of Antibodies Against SARS-CoV-2 in Wuhan, China
GHDx Entry last modified on: Jan 31, 2024
Prevalence of SARS-CoV-2 IgG antibodies in an area of northeastern Italy with a high incidence of COVID-19 cases: a population-based study
GHDx Entry last modified on: Mar 14, 2022
Contrasting SARS-CoV-2 epidemics in Singapore: Cohort studies in migrant workers and the general population. Preprint
GHDx Entry last modified on: Mar 14, 2022
Subscribe